Sushil Patel
Chief Executive Officer at REPLIMUNE GROUP, INC.
Net worth: 2 M $ as of 30/04/2024
Sushil Patel active positions
Companies | Position | Start | End |
---|---|---|---|
REPLIMUNE GROUP, INC. | Director/Board Member | 01/04/2024 | - |
Chief Executive Officer | 01/04/2024 | - | |
Public Communications Contact | 03/05/2021 | 03/01/2023 | |
Corporate Officer/Principal | 03/01/2023 | 01/04/2024 | |
REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 | - |
Independent Dir/Board Member | 16/06/2022 | - |
Career history of Sushil Patel
Former positions of Sushil Patel
Companies | Position | Start | End |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2008 | 01/05/2021 |
Training of Sushil Patel
Imperial College London | Graduate Degree |
University of London | Doctorate Degree |
University of Warwick | Undergraduate Degree |
Statistics
International
United States | 4 |
United Kingdom | 4 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
REPLIMUNE GROUP, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
Private companies | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sushil Patel
- Experience